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The human body constantly regenerates after damage due to the self-renewing and differentiating properties of its resident stem
cells. To recover the damaged tissues and regenerate functional organs, scientific research in the field of regenerative medicine is
firmly trying to understand the molecular mechanisms through which the regenerative potential of stem cells may be unfolded
into a clinical application. The finding that some organisms are capable of regenerative processes and the study of conserved
evolutionary patterns in tissue regeneration may lead to the identification of natural molecules of ancestral species capable to
extend their regenerative potential to human tissues. Such a possibility has also been strongly suggested as a result of the use of
physical energies, such as electromagnetic fields and mechanical vibrations in human adult stem cells. Results from scientific
studies on stem cell modulation confirm the possibility to afford a chemical manipulation of stem cell fate in vitro and pave the
way to the use of natural molecules, as well as electromagnetic fields and mechanical vibrations to target human stem cells in
their niche inside the body, enhancing human natural ability for self-healing.
1. Introduction
The human body continuously regenerates due to the
peculiar properties of its resident stem cells.
These cells possess the unique ability to self-renew and
differentiate, and the balance between these two processes
defines the stem cell fate and their primary role in tissue
regeneration [1].
Regeneration is the recovery of the organ structure and
function after injury and it is at the basis of our self-healing
potential and therefore of the preservation of human health.
Such a process exhibits remarkable grading in the way it is
fashioned in living organisms, since, within the same species,
the regenerative potential is different among the various
organs [2].
To rescue damaged tissues and restore functional
organ mass, huge efforts have been made in the growing
field of regenerative medicine, engaging scientific research
in the understanding of the molecular mechanisms
through which the regenerative potential of stem cells (as
human mesenchymal stem cells - hMSCs) may be unfolded
into a clinical application [3]. Stem cells in fact have the capa-
bility to differentiate into a wide range of adult cells and the
discovery and isolation of them paved the way to new hopes
in the regenerative field.
On the other hand, many aspects of the cell-based ther-
apy prevent the use of stem cells to regenerate organs and tis-
sues: among them, a large amount of stem cells is required
and the senescence process occurs during primary cell expan-
sion. Moreover, it is not easy to isolate stem cells and to
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commit all of them toward a specific phenotype, since they
can differentiate in all types of mature cells, including cancer
cells. Therefore, a proper set up of in vitro MSC expansion,
cryopreservation, and banking should be necessary to estab-
lish safety and efficacy in transplanted patients.
In addition, most of the applications of stem cells
directed on patients are still under the phase of experi-
mental trials, except for some procedures actually used in
clinical practice, as the bone marrow transplantation in
hematology [4].
Even tissue engineering, one of the branches of the regen-
erative medicine based upon tissue regeneration from cells
with the aid of biomaterials and growth factors, still is facing
several problems. In fact, the regenerated tissues usable by
patients are still very limited, as skin, bone, cartilage, capil-
lary, and periodontal tissues [5]. Moreover, the engineered
artificial tissue still exhibits some limitation correlated to
the dimensions of the construct that cannot be used for the
recovery of serious defects. Actually, the only amenable
engineered tissues with a tridimensional structure are vases,
cave structures like the trachea [6], or tissues which are not
physiologically scattered, since the viability of cells seeded
on a scaffold gradually decreases with thickness. Even the
use of growth factors alone or in association with 3D con-
structs is still considered as being not completely safe since
the resulting influence on recipient’s environment remains
in part to be established. Finally, other hurdles remain, such
as finding the best scaffold, the most suitable bioreactor,
and the optimal solution for seeding different cell popula-
tions in order to have a relevant mature material implantable
on patients.
All these issues need to be addressed before cells or
engineered constructs can be used routinely in the clinical
setting. Therefore, multiple studies have long been running
to address the modulation of relevant physiological traits
known to be involved in tissue homeostasis and in the
activation of the stem cell niches. To this end, besides
investigating the effects of synthetic molecules, many
researchers have also focused their attention on the effects
elicited by natural molecules and physical energies. Their
findings are reported below.
2. Natural Molecules
The ability to regrow body parts is common to a lot of animal
species, although the regenerative potential varies among
taxa [7]. Some phyla are able to rebuild every part of the
body, while others cannot regenerate internal organs [8].
Danio rerio (zebrafish) is among the organisms capable
of amazing regenerative processes, prompting the needs for
uncovering the underlying regeneration strategies. Zebrafish
is since recently commonly used as an animal model of
organogenesis and regeneration, owing to its ability to regen-
erate complex organs, like the heart, the central nervous sys-
tem, and the limbs, at an extraordinarily higher efficacy than
humans [2, 3, 9–16]. Another species exhibiting astonishing
regenerative potential is the Mexican axolotl (Ambystoma
mexicanum), which can make self-copies regenerating a
missing limb, tail, or parts of the brain, heart, and lower
jaw. Other creatures in the spotlight for their regenerative
capabilities are the salamanders, as well as several frogs
[17], or the tunicates [18]. Despite their evolutionary dis-
tance, as in the case of zebrafish which is separated by about
450 million years from humans, our stem cells can still sense
ancestral microenvironmental cues from these species, as
shown by the finding that human cord blood CD34+ cells
are recruited into early vasculogenesis upon transplantation
in pre-gastrulation, but not post-gastrulation zebrafish
embryos [19]. Akin to this view is the finding that conserved
transcriptional responses have been discovered among the
differentiation of hMSCs, Xenopus embryogenesis, and
axolotl regeneration, identifying common networks across
model species that are associated with depolarization
(changes in cellular resting potential) [20].
On the whole, these findings and the deployment of com-
parative biology into the analysis of conserved evolutionary
patterns in tissue regeneration may lead to the identification
of natural molecules capable to extend their regenerative
potential from ancestral species to human tissues through
the manipulation of common/similar mechanisms in their
resident stem cells.
Investigation of the role of natural molecules in stem cell
biology is becoming a growing area of inquiry. Psoralidin, for
example, a natural phenolic compound found in the seeds of
Psoralea corylifolia, has been seen to inhibit NOTCH1 in
breast cancer stem cells and in breast cancer cells, leading
to a growth arrest and inhibition of epithelial to mesen-
chymal transition (EMT) [21]. Moreover, two herbal
extracts (Tithonia diversifolia leaf extract and Momordica
foetida extract) led to a decrease of the adipogenesis and
accumulation of lipid droplets in human adipose-derived
stem cells (hADSCs) [22, 23]. Two natural compounds,
honokiol (a low-molecular-weight polyphenol isolated
from the genus Magnolia) and hyperoside (a flavonoid
compound extracted from Hypericum perforatum), were
shown to potentially induce the differentiation into neurons
in the murine embryonic carcinoma cell line P19 [24]. Syn-
thetic compounds created by the assembly of natural mole-
cules have also been proven effective in the modulation of
stem cell biology in vitro and in vivo. To this end, mixed
esters of naturally occurring molecules, such as hyaluronan
mixed esters with butyric and retinoic acids (HBR), have
been shown to remarkably increase cardiogenesis and vascu-
logenesis in mouse embryonic stem cells [25] and hMSCs
[26], enhancing the ability of term placenta hMSCs of pro-
moting the regeneration of infarcted myocardium in vivo in
both small (rat) and large (pig) animal models with post
infarct heart failure [27, 28]. Intriguingly, in the myocardium
of infarcted rats, HBR itself acted through the intracellular
release of its natural grafted molecules to afford significant
decrease in infarct size, and apoptotic myocytes, leading to
reverse myocardial remodeling, normalization in myocardial
contractility, and increase in vital myocardial mass and
metabolism, through the enhancement/recruitment of the
number of endogenous stro-1 (a mesenchymal stem cell
marker)-positive stem cells, the increase in the number of
local elements with pericyte identity and important revascu-
larization processes [29]. This finding shows the feasibility of
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chemical targeting damaged organs to afford tissue survival
and repair without stem cell transplantation. Consonant with
these results, a simple cocktail of hyaluronic, butyric, and
retinoic acids was able to improve islet graft revascularization
and function by adipose tissue-derived hMSCs in diabetic
rats [30].
The addition of melatonin to this mixture of natural
molecules was able to shift the commitment of hMSCs
towards an osteogenic fate, indicating the feasibility of cre-
ating a multicomponent, multitarget ensemble of natural
agents to chemically redirect the multilineage repertoire
of hMSCs [31].
A major breakthrough in the effort of using natural
arrays of molecules to drive cellular fates under normal and
pathological conditions came by the discovery that extracts
from zebrafish embryos obtained at different developmental
stages were able to counteract the proliferation rate of several
cancer cell lines [32–35]. Extracts from the beginning, inter-
mediate and final embryonic development stages led to an
evident increase in p53 expression in association with the
growth reduction [33]. In some cancer cell lines, such as
kidney adenocarcinoma, the proliferation decrease was asso-
ciated with changes in pRb phosphorylation, a cell cycle
modulator [34]. Moreover, in colon adenocarcinoma cells,
an activation of the p73-dependent apoptotic pathway was
observed [35]. A mixture of early, middle, and late develop-
mental stage zebrafish extracts was also able to enhance cell
survival to toxic stimuli, as shown by the reduction in mortal-
ity observed in cells from mouse hippocampal slices (CA1
area) that had been subjected to serum deprivation or
NMDA (N-methyl-D-aspartate) treatment [36]. These find-
ings and previous observations showing that embryonic
microenvironment is able to suppress tumor development
during cell differentiating processes [37, 38] led us to further
investigate whether zebrafish embryonic factors may also be
exploited in a developmental stage manner to control
essential features in stem cell dynamics. To this end, we suc-
cessfully used early-stage developmental zebrafish extracts
(obtained from 5.15 hours post fertilization embryos) on
early-passage hADSCs to enhance the stem cell expression
of multipotency, and the transcription of TERT, encoding
the catalytic subunit of telomerase, as well as the gene expres-
sion of BMI1, a chromatin remodeler acting as a major
telomerase-independent repressor of senescence [39].
On the whole, the above mentioned studies, showing the
possibility to afford a chemical manipulation of stem cell fate
in vitro, may pave the way to the use of natural or synthetic
chemistry to target human stem cells where they are already
resident in all body tissues. This would lead to the develop-
ment of a regenerative medicine executed without the needs
for (stem) cell or tissue transplantation.
3. Physical Energies
The possibility of using physical energies to boost regenera-
tive processes has been strongly suggested by the ability of
electromagnetic fields and mechanical vibrations to drive
efficient in situ reprogramming of the differentiating and
regenerative potential of our endogenous stem cells.
We are in fact embedded in a wide variety of physical
stimuli, including electromagnetic fields, light radiation,
and mechanical oscillatory patterns. In this sense, our life
which contains a seeming infinity of rhythmic oscillations,
including calcium and pH intracellular oscillations [40–42],
as well as the rhythmic expression of genes and proteins
[43, 44], can be considered as a part of the vibratory nature
of the universe.
It is now evident that our cells perceive and generate
energies like magnetic fields and mechanical oscillations
[45–47]. Cells contain a network of microtubules that, due
to their electrical polarity and intrinsic vibration modes, is
able to generate high-frequency electric fields with radiation
features [48]. Applying scanning tunneling microscopy
(STM) to microtubules growing onto a nanoelectrode array,
within an artificial cell replica designed to pump electromag-
netic frequencies, has shown the existence of resonance
patterns between the tubulin dimers, or the whole microtu-
bules, and the applied frequencies [49]. STM also provided
evidence that such resonance patterns could be imaged as
specific “tunneling current profiles” corresponding to the
pumped electromagnetic frequencies [49]. The frequency
region selectivity for engaging particular types of conforma-
tional modifications establishes that pure mechanical
changes can be remotely managed in an atomically way by
using electromagnetic fields.
The importance of the microtubule network as an
information-transporting-system is also deduced by the
finding of multilevel memory-switching properties in a
single brain microtubule [50]. Even DNA, despite its role of
storage and expression of genetic information, when consid-
ered as an electrically charged vibrational entity, may
contribute to cell polarity, also by virtue of its constant
assembly into different loops and domains that are an essen-
tial component of the nanomechanics and nanotopography
imparted to this macromolecule by transcription factors
and molecular motors. Accordingly, electromagnetic reso-
nance frequency spectra have been revealed for DNA, which
was found to exhibit electromagnetic resonances in the wide
frequency range from KHz, MHz, GHz, to THz [51].
Recently, regenerative medicine has been focused on the
use of biophysical stimuli to modulate cellular dynamics
[52]. Physical factors in the cellular microenvironment,
including matrix mechanics, cell geometry and shape,
mechanical forces, and nanotopographical aspects of the
extracellular matrix, can modulate the stem cell fate [53, 54].
There is evidence that this type of regulation is highly
affected by coexisting insoluble, adhesive, mechanical,
and topological cues contained and dynamically regulated
within the stem cell niche [55, 56]. Biophysical stimuli
can be sensed and transduced into intracellular biochemi-
cal and functional responses by stem cells, a process
known as mechano-transduction [55]. The stem cell sen-
sory machinery can at the same time perceive and inte-
grate several signals from the niche and turn them into
coherent responses affording downstream modulation of
gene expression and stem cell fate [55, 57–59].
For years, scientists tried to drive stem cell fate by the aid
of chemistry, increasing cell proliferation with growth factors
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or fabricating 3D constructs derived from the combination of
stem cells or mature adult cells, with natural or artificial poly-
mers. Only in the last years, efforts have been made to inter-
act with cells in vivo, directly on patients or on animal
models, and in vitro on cell cultures. Recently, some research
groups have shown the possibility to use physical stimuli
directly on patients, tissues, and cells [60].
The idea behind the use of physical stimuli on tissues and
body was already proposed in 1974 by Richard Nuccitelli
who gained evidence on endogenous ionic current and inter-
action with electric field in multicellular animal tissues [61].
Nowadays, it is possible to explain changes in cellular behav-
ior, following electromagnetic stimulation, considering an
effect on cell polarity [62] and on the stem cell niche in the
body [63].
The use of physical energies for therapeutic purpose is
now well known, being approved by the Food and Drug
Administration (FDA) and used on patients. Several devices
based on different physical mechanisms have been designed,
and the beneficial effects have been observed directly on
patients. Ultrasounds have been used for medical purposes
since the 1950 in some pathological situations, such as
tendinitis or bursitis [64].
Even the use of extremely low-frequency electromagnetic
fields (ELF-EMFs) with frequencies lower than 100Hz, and
magnetic field intensity spanning from 0.1 to 20mT, became
a useful therapy for soft tissue regeneration, fracture repair,
and osteoporosis treatment [65]. The mechanisms of action
of ELF-EMFs are not clear yet. However, it has been shown
that electric currents can accelerate cell activation [66] and
influence epigenetic remodeling. In particular, the use of
50Hz ELF-EMF on GC-2 cells decreased genome-wide
methylation and the expression of DNA methyltransferases
[67] in neural stem cells (NSCs) isolated from the hippocam-
pus of newborn mice. Moreover, the ELF-EMF irradiation at
1mT, and 50Hz, for 12 days enhanced NSC proliferation
and neuronal cell fate specification through Cav1 channel-
dependent regulation and histone modification [68]. These
results show the feasibility of using physical stimuli to affect
cell fate.
Within this context, we have first demonstrated the pos-
sibility to use ELF-EMFs to modulate the gene transcription
of essential growth regulatory peptides in adult myocardial
cells [60] and to enhance cardiogenesis and terminal differ-
entiation into spontaneously beating myocardial cells in
mouse embryonic stem (ES) cells [69]. Then, by the aid of a
radio electric asymmetric conveyer (REAC), we found that
properly conveyed radioelectric fields of 2.4GHz could
produce important biological effects in mouse ES cells and
human adult stem cells. In both cell types, we showed that
REAC-conveyed radioelectric fields elicited an increase of
the expression of stemness-related genes, followed by the
commitment towards neuronal, myocardial, and skeletal
muscle lineages [70, 71]. The same differentiating outcomes
were induced by REAC exposure in human skin fibroblasts
[72]: for the first time, human non-stem somatic adult cells
were committed to lineages in which they would never other-
wise appear. This effect was mediated by a biphasic change in
pluripotency gene expression, a temporary overexpression
followed by a down regulation, and did not require the use
of viral vector-mediated gene transfer technologies or
cumbersome synthetic chemistry.
Noteworthy, REAC exposure of hADSCs was able to
turn stem cell senescence, occurring after prolonged (up
to 30 passage) in vitro expansion, into a reversible phe-
nomenon, associated with a decrease in the expression of
senescence-associated β-galactosidase and an increase in
TERT gene expression and telomere length. The REAC
action also enhanced the gene transcription of BMI1 and
that of stemness-related genes, establishing a telomerase-
independent arm for senescence reversal [73]. These findings
may have important biomedical implications, since senescent
stem cells decrease their self-renewal and differentiation
potential, reducing their ability for tissue regeneration
in vivo and the possibility of a prolonged expansion in vitro
prior to transplantation.
Compounding the wide-ranging biological effects of
REAC stimulation is the observation that this technology
was able to promote neurological and morphofunctional dif-
ferentiation in PC12 cells [74], a rat adrenal pheochromocy-
toma cell line displaying metabolic features of Parkinson’s
disease. Cell response to the electromagnetic field was medi-
ated by the transcriptional activation of neurogenic genes, as
neurogenin-1, β3-tubulin, and nerve growth factor (NGF),
and was associated with a consistent increase in the number
of cells expressing both β3-tubulin and tyrosine hydroxylase
[74]. These findings open the new perspective of using
physical energies in the treatment of neurodegenerative dis-
eases and in the reprogramming of cancer (stem) cells into
normal regenerative elements. More recently, we found that
the REAC action could be significantly counteracted by stem
cell treatment with 4-methylumbelliferone (4-MU), a potent
repressor of type-2 hyaluronan (HA) synthase and endoge-
nous HA synthesis [75]. This observation suggests that
REAC-mediated responses may have occurred through an
essential pleiotropic role of this glycosaminoglycan in regu-
lating (stem) cell polarity.
Extracorporeal shock waves (ESW) represent another
type of biophysical stimuli that is increasingly being applied
in the field of regenerative medicine and that could be classi-
fied as “mechanotherapy” (i.e., extracorporeal shock wave
therapy, ESWT). In fact, ESW are “mechanical” waves, char-
acterized by an initial positive very rapid phase, of high
amplitude, followed by negative pressure, producing a
“microexplosion” that can be directed on a target zone (body,
tissue, or cells) in order to stimulate or modify the cells in
their behavior. Shock waves are generated by an electrohy-
draulic device that produces underwater high-voltage con-
denser spark discharge, conveyed by an elliptical reflector
on tissues or cells.
In the 1980s, shock waves were used in urology (litho-
tripsy) to disintegrate renal stones [76]. Then, ESW applica-
tion has been extended to other fields, showing promising
hopes for promoting tissue healing and the recovery from
pathological disorders. One of the first applications was in
the orthopedic field, in order to induce neovascularization
and improve blood supply and tissue regeneration. Investiga-
tions on the use of this technology spread progressively, and
4 Stem Cells International
leading to its application in the treatment of musculoskeletal
disorders [77], tendon pathologies [78], bone healing distur-
bances, and vascular bone diseases [79]. The use of ESW has
also been extended to the field of dermatology for the wound
healing disturbances and ulcers. However, to date, the exact
mechanism through which cells convert mechanical signals
into biochemical responses is not well understood yet.
Emphasis has been placed so far into mechanisms medi-
ated by ATP release and P2 receptor activation that may
foster cell proliferation and tissue remodeling via Erk1/2
activation [80, 81], as well as PI-3K/AKT and NF-κB sig-
naling pathways, and the implication of TLR3 signaling
and subsequent TLR4. Several studies performed in vitro
proved the effect of ESW on cell modulation through
“mechano-transduction”. Recently, ESW were found to
activate ADSCs through MAPK, PI-3K/AKT, and NF-κB
signaling pathways [82, 83] and to induce in HUVEC cells
an overexpression of angiogenic factors and of caveolin-1,
a constitutive protein of caveolae, implicated in the regula-
tion of cell growth, lipid trafficking, endocytosis, and cell
migration [84].
In addition, the ESWT effect on cell behavior proved to
be a dose-dependent phenomenon. In a study published by
Zhang and coworkers, cells exposed to low-energy ESW
(0.04 e 0.13mJ/mm2) improved the expression of some
angiogenic factors, such as eNOS, Ang-1, and Ang-2. On
the other hand, at higher energy, ESW induced a reduction
in angiogenic factor expression and an increase in apoptosis
[85]. These findings suggest that the biological effects of
shock waves strongly correlated with the intensity of applied
energy and thus with the related mechanical forces.
Recently, the effects of shock waves have been charac-
terized on the expression of IL-6, IL-8, MCP-1, and TNF-α
in human periodontal ligament fibroblasts [86]. Following
an early inhibition on the expression of pro-inflammatory
mediators, shock waves elicited a dose-related increase in
IL-6 and IL-8, while down-regulating TNF-α expression
[86]. Most of the literature showed an anti-inflammatory
effect of ESWT in vivo [59, 78, 79, 87, 88]. Nevertheless, the
pro-inflammatory effect of ESWT partially observed on
cells in vitro may suggest a pro-activator event mediated
by cytokine and chemokine expression. It was supposed
that the shock wave impulses on cells were able to create
a pro-inflammatory milieu, mediated by mechano-
transduction [80]. However, this mechanism may involve
a more complex action on the whole niche architecture,
with the embedded (stem) cells behaving as sensors and
activators of the regenerative response.
In actual fact, mechanical vibration may represent a
relevant modality to affect stem cell reprogramming in vivo
without having to resort to transplantation procedures. In
this regard, we have shown and patented for the first time
the cell ability to exhibit “vibrational” (nanomechanical) sig-
natures of their health and their multilineage repertoire [89].
Wide-ranging vital processes are fashioned around the
nanomechanical features of subcellular structures, like the
microtubular networks, imparting feature characteristic of
connectedness and synchronization that can be transferred
and recorded from the cell surface. Atomic force microscopy
(AFM) can be used to gain insights on cellular nanomechan-
ical properties [89, 90], providing the chance to identify
vibrational signatures that can be used to drive lineage-
specific commitments in different stem cell populations
in vitro or even in vivo to promote endogenous rescue in
diseased organs.
4. Conclusion
The emerging view of a (stem) cell biology governed by
physical forces and influenced by ancestral natural mole-
cules may lead us to reinterpret the way we envision the
field of regenerative medicine for a near future.
In fact, due to the diffusive nature of electromagnetic
fields and mechanical vibrations, the chance is emerging
to target and reprogram the stem cells where they are,
enhancing our natural ability for self-healing without the
needs for (stem) cell transplantation which still shows
remarkable limitations.
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